A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

For Type 1 diabetes, immunotherapy approaches aim to prevent or reverse the autoimmune destruction of beta cells, while cell replacement therapies seek to restore insulin production through ...

In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...

Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice ...

according to a doctor Type 1 diabetes is an autoimmune disease where beta cells, a hormone located in the pancreas that ...

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

The class, or form, named type 1 diabetes encompasses the vast majority of cases that are primarily due to pancreatic islet beta-cell destruction and that are prone to ketoacidosis. This form ...

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

Antibiotic Exposure in Infancy May Boost Type 1 Diabetes ... loss and diabetes ... Mar. 4, 2025 — Researchers have discovered a novel approach to protecting insulin-producing beta cells from ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.